基于脂质体的混合药物递送系统与DNA纳米结构和金属纳米粒子
Olavi Reinsalu1, Mart Ernits1, Veikko Linko1,2
1Institute of Technology, University of Tartu, Tartu, Estonia.
Expert opinion on drug delivery
|July 4, 2024
概括
新型混合组件将脂质体与核酸纳米结构和金属纳米粒子合并,用于先进的药物输送. 这些创新的结构提供了增强的多功能性,生物相容性和药物加载能力.
科学领域:
- 纳米技术 纳米技术
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
背景情况:
- 脂质体配方广泛用于药物输送.
- 与其他纳米物体的集成提供了增强性能的潜力.
- 混合组件将脂质体与核酸纳米结构或金属纳米粒子结合起来.
研究的目的:
- 审查基于脂质体配方的新型混合组件.
- 要突出结合脂质体与核酸纳米结构和金属纳米颗粒的构造.
- 介绍先进药物输送平台的桥梁技术的例子.
主要方法:
- 关于混合脂体组件的最新文献的综述.
- 专注于将脂质体与DNA原形,金属纳米粒子和金属有机框架相结合的例子.
- 讨论在药物输送及其他领域的应用.
主要成果:
- 混合组件展示了多功能,生物相容性和高药物负载的潜力.
- 具体的例子展示了各种纳米材料与脂质体的集成.
- 这些混合系统为有针对性的治疗应用提供可调节的特性.
结论:
- 将脂质体与纳米结构合并可以创建先进的药物输送载体.
- 未来的策略可能涉及动态DNA纳米结构和人造脂质体集群的脂质体.
- 潜在的应用包括检查蛋白质相互作用和增强药理动力学特性.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


